Literature DB >> 17639022

Interaction between Munc13-1 and RIM is critical for glucagon-like peptide-1 mediated rescue of exocytotic defects in Munc13-1 deficient pancreatic beta-cells.

Edwin P Kwan1, Li Xie, Laura Sheu, Toshihisa Ohtsuka, Herbert Y Gaisano.   

Abstract

OBJECTIVE: Glucagon-like peptide-1 (GLP-1) rescues insulin secretory deficiency in type 2 diabetes partly via cAMP actions on exchange protein directly activated by cAMP (Epac2) and protein kinase A (PKA)-activated Rab3A-interacting molecule 2 (Rim2). We had reported that haplodeficient Munc13-1(+/-) mouse islet beta-cells exhibited reduced insulin secretion, causing glucose intolerance. Munc13-1 binds Epac2 and Rim2, but their functional interactions remain unclear. RESEARCH DESIGN AND METHODS: We used Munc13-1(+/-) islet beta-cells to examine the functional interactions between Munc13-1 and Epac2 and PKA. GLP-1 stimulation of Munc13-1(+/-) islets normalized the reduced biphasic insulin secretion by its actions on intact islet cAMP production and normal Epac2 and Rim2 levels.
RESULTS: To determine which exocytotic steps caused by Munc13-1 deficiency are rescued by Epac2 and PKA, we used patch-clamp capacitance measurements, showing that 1) cAMP restored the reduced readily releasable pool (RRP) and partially restored refilling of a releasable pool of vesicles in Munc13-1(+/-) beta-cells, 2) Epac-selective agonist [8-(4-chloro-phenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate] partially restored the reduced RRP and refilling of a releasable pool of vesicles, and 3) PKA blockade by H89 (leaving Epac intact) impaired cAMP ability to restore the RRP and refilling of a releasable pool of vesicles. Conversely, PKA-selective agonist (N(6)-benzoyladenosine-cAMP) completely restored RRP and partially restored refilling of a releasable pool of vesicles. To determine specific contributions within Epac-Rim2-Munc13-1 interaction sites accounting for cAMP rescue of exocytosis caused by Munc13-1 deficiency, we found that blockade of Rim2-Munc13-1 interaction with Rim-Munc13-1-binding domain peptide abolished cAMP rescue, whereas blockade of Epac-Rim2 interaction with Rim2-PDZ peptide only moderately reduced refilling with little effect on RRP.
CONCLUSIONS: cAMP rescue of priming defects caused by Munc13-1 deficiency via Epac and PKA signaling pathways requires downstream Munc13-1-Rim2 interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639022     DOI: 10.2337/db06-1207

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  29 in total

1.  A model for sealing plasmalemmal damage in neurons and other eukaryotic cells.

Authors:  Christopher S Spaeth; Elaine A Boydston; Lauren R Figard; Aleksej Zuzek; George D Bittner
Journal:  J Neurosci       Date:  2010-11-24       Impact factor: 6.167

2.  Noradrenaline inhibits exocytosis via the G protein βγ subunit and refilling of the readily releasable granule pool via the α(i1/2) subunit.

Authors:  Ying Zhao; Qinghua Fang; Susanne G Straub; Manfred Lindau; Geoffrey W G Sharp
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

3.  Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM.

Authors:  Grant G Kelley; Oleg G Chepurny; Frank Schwede; Hans-G Genieser; Colin A Leech; Michael W Roe; Xiangquan Li; Igor Dzhura; Elvira Dzhura; Parisa Afshari; George G Holz
Journal:  Islets       Date:  2009 Nov-Dec       Impact factor: 2.694

4.  Cab45b, a Munc18b-interacting partner, regulates exocytosis in pancreatic beta-cells.

Authors:  Yi Zhang; You-Hou Kang; Nathan Chang; Patrick P L Lam; Yunfeng Liu; Vesa M Olkkonen; Herbert Y Gaisano
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

Review 5.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

6.  Epac2-dependent mobilization of intracellular Ca²+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-ε knockout mice.

Authors:  Igor Dzhura; Oleg G Chepurny; Grant G Kelley; Colin A Leech; Michael W Roe; Elvira Dzhura; Parisa Afshari; Sundeep Malik; Michael J Rindler; Xin Xu; Youming Lu; Alan V Smrcka; George G Holz
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

7.  Epac activates the small G proteins Rap1 and Rab3A to achieve exocytosis.

Authors:  María T Branham; Matías A Bustos; Gerardo A De Blas; Holger Rehmann; Valeria E P Zarelli; Claudia L Treviño; Alberto Darszon; Luis S Mayorga; Claudia N Tomes
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

Review 8.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

9.  PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans.

Authors:  Oleg G Chepurny; Grant G Kelley; Igor Dzhura; Colin A Leech; Michael W Roe; Elvira Dzhura; Xiangquan Li; Frank Schwede; Hans-G Genieser; George G Holz
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

Review 10.  Mechanisms of biphasic insulin-granule exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins.

Authors:  Zhanxiang Wang; Debbie C Thurmond
Journal:  J Cell Sci       Date:  2009-04-01       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.